Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MIRIKIZUMAB
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
- A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
- A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants
- A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease (AMAY)
- A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- A Study of Mirikizumab in Healthy Participants
- A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants
- A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis
- A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
- A Study of Mirikizumab in Healthy Chinese Participants
- A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
- A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
- A Study of Mirikizumab in Participants With Plaque Psoriasis
- A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
- A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
- A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
- A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
- A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis
- A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
- A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
- A Study of Mirikizumab (LY3074828) in Healthy Participants
Clinical trials list
click for details